Vanguard Group Inc Ngm Biopharmaceuticals Inc Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Ngm Biopharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,324,392 shares of NGM stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,324,392
Previous 2,770,574
16.1%
Holding current value
$0
Previous $2.38 Million
55.12%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding NGM
# of Institutions
78Shares Held
36.9MCall Options Held
1.1KPut Options Held
200-
Column Group LLC San Francisco, CA18.1MShares$017.97% of portfolio
-
Black Rock Inc. New York, NY3MShares$00.0% of portfolio
-
Step Stone Group LP La Jolla, CA1.57MShares$00.6% of portfolio
-
Ponoi Ii Management, LLC San Francisco, CA1.3MShares$044.41% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.3MShares$023.2% of portfolio
About NGM BIOPHARMACEUTICALS INC
- Ticker NGM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,365,904
- Description
- NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...